Definition and classification of cancer cachexia: an international consensus
2011 · The Lancet Oncology · 5,418 citations
https://doi.org/10.1016/s1470-2045(10)70218-7
C
Charles L. Loprinzi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
838
Papers
47.9K
Citations
107
h-index
425
i10-index
Charles L. Loprinzi is an academic researcher from Mayo Clinic in Arizona. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Estrogen and related hormone effects & Chemotherapy-related skin toxicity. The author has an h-index of 107, co-authored 713 publications.
ORCID: 0000-0001-8044-5752Papers by this author
worksPrevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 · Journal of Clinical Oncology · 1,198 citations
https://doi.org/10.1200/jco.2013.54.0914
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
2020 · Journal of Clinical Oncology · 963 citations
https://doi.org/10.1200/jco.20.01399
Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline
2017 · Journal of Clinical Oncology · 546 citations
https://doi.org/10.1200/jco.2017.75.2311
Soy for Breast Cancer Survivors: A Critical Review of the Literature
2001 · Journal of Nutrition · 362 citations
https://doi.org/10.1093/jn/131.11.3095s
Troublesome Symptoms in Cancer Survivors: Fatigue, Insomnia, Neuropathy, and Pain
2012 · Journal of Clinical Oncology · 276 citations
https://doi.org/10.1200/jco.2012.41.7238
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat